The Routine Cataract Removal with Intraocular Lens (IOL) Implantation cost measure evaluates clinicians’ risk-adjusted cost to Medicare for beneficiaries who receive this procedure. The cost measure score is a clinician’s average risk-adjusted cost for the episode group averaged across all episodes attributed to the clinician. This procedural measure includes costs of services that are clinically related to the attributed clinician’s role in managing care during the 60 days prior to the clinical event that opens or ‘triggers’ the episode, through 90 days after the trigger. Beneficiary populations eligible for the Routine Cataract Removal with IOL Implantation measure include Medicare beneficiaries enrolled in Medicare Parts A and B during the performance period.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.20 Testing Data Sources
-
OLD 1.12 MAT output not attachedAttached
-
Most Recent Endorsement ActivityEndorsed Cost and Efficiency Spring Cycle 2019Initial EndorsementLast Updated
-
Steward Organization Email
-
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-